Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Ovarian Neoplasms and MS[original query] |
|---|
| Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers. Breast cancer research and treatment 2007 May 103 (1): 29-36. Pepe C, Guidugli L, Sensi E, Aretini P, D'Andrea E, Montagna M, Manoukian S, Ottini L, Radice P, Viel A, Bevilacqua G, Caligo M |
| No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk. Breast cancer research and treatment 2010 Jun 121 (2): 497-502. Andonova Irena E, Justenhoven Christina, Winter Stefan, Hamann Ute, Baisch Christian, Rabstein Sylvia, Spickenheuer Anne, Harth Volker, Pesch Beate, Brüning Thomas, Ko Yon-Dschun, Ganev Varban, Brauch Hiltr |
| The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment 2011 Apr 126 (2): 521-7. Kaufman Bella, Laitman Yael, Ziv Elad, Hamann Ute, Torres Diana, Lahad Ephrat Levy, Beeri Rachel, Renbaum Paul, Jakubowska Anna, Lubinski Jan, Huzarski Tomasz, To?oczko-Grabarek Aleksandra, Jaworska Katarzyna, Durda Katarzyna, Sprudle Amanda B, Chenevix-Trench Georgia, Simard Jacques, Easton Douglas F, Antonis Antoniou, Szabo Csilla, Friedman Eit |
| Pyrimidine base damage is increased in women with BRCA mutations. Cancer letters 2013 Sep 338 (2): 267-70. Budzinski Edwin E, Patrzyc Helen B, Dawidzik Jean B, Freund Harold G, Frederick Peter, Godoy Heidi E, Voian Nicoleta C, Odunsi Kunle, Box Harold |
| Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer. Genetics in medicine : official journal of the American College of Medical Genetics 2021 Jun . Woodward Emma R, van Veen Elke M, Forde Claire, Harkness Elaine F, Byers Helen J, Ellingford Jamie M, Burghel George J, Schlech Helene, Bowers Naomi L, Wallace Andrew J, Howell Sacha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam J, Gareth Evans |
| Integration of tumour sequencing and case-control data to assess pathogenicity of RAD51C missense variants in familial breast cancer. NPJ breast cancer 2022 1 8 (1): 10. Lim Belle W X, Li Na, Rowley Simone M, Thompson Ella R, McInerny Simone, Zethoven Magnus, Scott Rodney J, Devereux Lisa, Sloan Erica K, James Paul A, Campbell Ian |
| Development and validation of a sensitive LC-MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients. Journal of pharmaceutical and biomedical analysis 2023 10 237 115758. Yuru Wei, Haixi Liang, Shu Liu, Shaoxing Guan, Kaiyun Ma, Yanping Guan, Youhao Chen, Min Huang, Xueding Wang, Chunyan L |
| Benzo[a]pyrene exposure affects colorectal cancer susceptibility by regulating ER?-mediated LINC02977 transcription. Environment international 2024 1 184 108443. Shuai Ben, Shuwei Li, Dongying Gu, Lingyan Zhao, Shenya Xu, Zhutao Ding, Silu Chen, Yifei Cheng, Junyi Xin, Mulong Du, Meilin Wa |
- Page last reviewed:Feb 1, 2024
- Content source: